Revolutionary new class of personalized cancer drugs
OncoStem Biotherapeutics is an emerging Biotech company with a proprietary data base of unique cancer causing genes identified by application of Bioinformatics to Systems Biology and Network Theory revealing unique cancer gene targets for the development of a whole new class of personalized cancer drugs. Current targeted cancer drug therapy has stalled. We have partnered with Columbia University's Genome Center to produce first in class oral targeted cancer drugs designed to treat an individual's specific cancer..
Mentions in press and media 1